Citations (14)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Shalini & Vipan Kumar. (2021) Have molecular hybrids delivered effective anti-cancer treatments and what should future drug discovery focus on?. Expert Opinion on Drug Discovery 16:4, pages 335-363.
Read now
Read now
Paul Dent. (2019) Investigational CHK1 inhibitors in early phase clinical trials for the treatment of cancer. Expert Opinion on Investigational Drugs 28:12, pages 1095-1100.
Read now
Read now
Clint Mitchell, Hossein A. Hamed, Nichola Cruickshanks, Yong Tang, M. Danielle Bareford, Nissan Hubbard, Gary Tye, Adly Yacoub, Yun Dai, Steven Grant & Paul Dent. (2011) Simultaneous exposure of transformed cells to SRC family inhibitors and CHK1 inhibitors causes cell death. Cancer Biology & Therapy 12:3, pages 215-228.
Read now
Read now
Articles from other publishers (11)
Ankit Kumar Singh, Adarsh Kumar, Harshwardhan Singh, Pankaj Sonawane, Harshali Paliwal, Suresh Thareja, Prateek Pathak, Maria Grishina, Mariusz Jaremko, Abdul-Hamid Emwas, Jagat Pal Yadav, Amita Verma, Habibullah Khalilullah & Pradeep Kumar. (2022) Concept of Hybrid Drugs and Recent Advancements in Anticancer Hybrids. Pharmaceuticals 15:9, pages 1071.
Crossref
Crossref
Wei Wang, Yue Sun, Xiaobo Liu, Shaji K. Kumar, Fengyan Jin & Yun Dai. (2022) Dual-Targeted Therapy Circumvents Non-Genetic Drug Resistance to Targeted Therapy. Frontiers in Oncology 12.
Crossref
Crossref
Chuanshan Zhang, Jing Li, Tuerganaili Aji, Liang Li, Xiaojuan Bi, Ning Yang, Zhide Li, Hui Wang, Rui Mao, Guodong Lü, Yingmei Shao, Dominique A. Vuitton, Hao Wen & Renyong Lin. (2019)
Identification of Functional MKK3/6 and MEK1/2 Homologs from Echinococcus granulosus and Investigation of Protoscolecidal Activity of Mitogen-Activated Protein Kinase Signaling Pathway Inhibitors
In Vitro
and
In Vivo
. Antimicrobial Agents and Chemotherapy 63:1.
Crossref
Crossref
MEI HONG ZHANG, HONG TAO MAN, XIAO DAN ZHAO, NI DONG & SHI LIANG MA. (2014) Estrogen receptor-positive breast cancer molecular signatures and therapeutic potentials (Review). Biomedical Reports 2:1, pages 41-52.
Crossref
Crossref
Yun Dai, Shuang Chen, Liang Yi & Minhui Xu. 2013. Trends in Stem Cell Proliferation and Cancer Research. Trends in Stem Cell Proliferation and Cancer Research
591
654
.
Clint Mitchell, Margaret Park, Patrick Eulitt, Chen Yang, Adly Yacoub & Paul Dent. (2010) Poly(ADP-Ribose) Polymerase 1 Modulates the Lethality of CHK1 Inhibitors in Carcinoma Cells. Molecular Pharmacology 78:5, pages 909-917.
Crossref
Crossref
Margaret A. Park, Guo Zhang, Clint Mitchell, Mohamed Rahmani, Hossein Hamed, Michael P. Hagan, Adly Yacoub, David T. Curiel, Paul B. Fisher, Steven Grant & Paul Dent. (2008)
Mitogen-activated protein kinase kinase 1/2 inhibitors and 17-allylamino-17-demethoxygeldanamycin synergize to kill human gastrointestinal tumor cells
in vitro
via suppression of c-FLIP-s levels and activation of CD95
. Molecular Cancer Therapeutics 7:9, pages 2633-2648.
Crossref
Crossref
Yun DaiPayal KhannaShuang ChenXin-Yan PeiPaul Dent & Steven Grant. (2007) Statins synergistically potentiate 7-hydroxystaurosporine (UCN-01) lethality in human leukemia and myeloma cells by disrupting Ras farnesylation and activation. Blood 109:10, pages 4415-4423.
Crossref
Crossref
Kiyohiko Hatake, Nahomi Tokudome & Yoshinori Ito. (2007) Next generation molecular targeted agents for breast cancer: focus on EGFR and VEGFR pathways. Breast Cancer 14:2, pages 132-149.
Crossref
Crossref
Reinhold Schäfer, Oleg I. Tchernitsa, Balazs Györffy, Violeta Serra, Rula Abdul-Ghani, Per Lund & Christine Sers. (2007) Functional transcriptomics: An experimental basis for understanding the systems biology for cancer cells. Advances in Enzyme Regulation 47:1, pages 41-62.
Crossref
Crossref
Xin-Yan Pei, Weiqun Li, Yun Dai, Paul Dent & Steven Grant. (2006) Dissecting the Roles of Checkpoint Kinase 1/CDC2 and Mitogen-Activated Protein Kinase Kinase 1/2/Extracellular Signal-Regulated Kinase 1/2 in Relation to 7-Hydroxystaurosporine-Induced Apoptosis in Human Multiple Myeloma Cells. Molecular Pharmacology 70:6, pages 1965-1973.
Crossref
Crossref